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Abstract 
The prion protein (PrP) is a membrane-anchored cell surface glycoprotein containing 231 
amino acids. It has been associated with a group of neurodegenerative disorders. Copper(II) 
interaction with the  Human Prion 103-112 fragment and its mutants has been studied with 
various techniques. The studied human prion fragment contains both histidine and methionine 
residues, while methionine residues are systematically replaced or displaced in the studied 
mutants. pH-potentiometric, UV-vis and circular spectroscopic techniques were applied to 
study the stoichiometry, stability and structure of the copper(II) complexes, while HPLC-MS 
and MS/MS were used for identifying the products of copper(II) catalyzed oxidation. The 
complex formation reactions of the studied ligands are rather similar; only 1:1 complexes are 
formed, where the imidazole nitrogen of the histidine residue is the main binding site beside 
the amide nitrogens of the peptide chain. The only difference is, that in the peptides which 
contain methionine in position 109, in addition to the (Nim,N−,N−) coordination mode, a weak 
interaction  of thioether sulfur atoms can be supposed. The mutant peptide which does not 
contain methionine did not undergo oxidation, only the fragmentation of the peptide chain 
was perceived. However, in the case of methionine containing peptides, the peptide chain was 
not cleaved; but the oxidation of methionine to methionine sulfoxide occurred. 
 
 
1. Introduction 
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The prion protein (PrP) is a membrane-anchored cell surface glycoprotein containing 231 
amino acids. It consists of a helical C-terminal domain (residues 121-231) and a flexible and 
largely unstructured N-terminal domain (residues 23-120) [1,2]. It has been associated with a 
group of invariably fatal neurodegenerative disorders called transmissible spongiform 
encephalopathies (TSEs) which affect both humans (e.g. Creutzfeldt-Jakob Disease, 
Gerstmann-Straussler-Scheinker Syndrome, Fatal Familial Insomnia, Kuru) and animals (e.g. 
Bovine Spongiform Encephalopathy, Chronic Wasting Disease, Scrapie). Prion diseases may 
present as genetic, infectious, or sporadic disorders, all of which involve modification of the 
prion protein. The normal, cellular PrP, denoted PrPC, is converted into scrapie PrP (PrPSc) 
through a process whereby a portion of its α-helical and coil structure is refolded into β-sheet 
[3]. This structural transition is accompanied by profound changes in the physicochemical 
properties of the PrP. PrP is most abundant in the central nervous and immune systems, but it 
is also expressed in other biological compartments [4]. Its physiological function has not been 
determined yet [5,6]. However, the property of PrPC to bind Cu(II) ions in vivo and in vitro 
suggests that its function relates to copper homeostasis or to copper-dependent enzymatic 
functions [7,8]. Several reports can be found about the binding affinity of copper(II) ions to 
PrP. There is a general consensus about that PrP can bind at least six copper(II) ions; four 
copper-binding sites are present in the octarepeat region (residues 60-91), and the region 
between the octarepeat and the C-terminal structured domain (residues 90–126) provides two 
further copper(II) binding sites, each associated with a histidine residue [9]. All these binding 
sites are taking part in the coordination of copper(II) ions in equimolar solutions, which 
results in the formation of coordination isomers. However, these binding sites are not 
equivalent; the predominance of the isomer with His111 binding is obtained [10]. The 
presence of Met109 residue in the vicinity of His 111 may contribute to the enhanced stability 
of these species. A weak interaction between the thioether function of Met109 residues and 
copper(II) ions is suggested.  
In addition to the complex formation, the metal ions and their small molecule complexes can 
play an important role in various oxidative reactions of peptides. Metal catalyzed oxidation 
(MCO) is a hallmark of oxidative stress and accompanies biological aging and 
neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease [11]. Accordingly, 
the coordination of copper(II) ion toward PrP is extensively studied, however the copper 
catalyzed oxidation of prion protein is the central question in several researches.   
The investigation of metal ion catalyzed oxidation is a rapidly growing area in the 
coordination chemistry of peptides, the significance of these reactions is especially important 
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in the understanding of the mechanism of various neurodegenerative disorders. Curtain et al. 
suggested that metal ions play a pivotal role in the generation of reactive oxygen species 
(ROS) [12]. The oxidative modification of specific amino acid residues in proteins may lead 
to loss or gain of function, changes in protein conformation and turnover and/or protein-
protein interactions. The metal ion-catalyzed oxidation of biomolecules involves reduction of 
Fe(III) or Cu(II) by a suitable electron donor such as NADH, NADPH, ascorbate or thiols. 
Fe(II) and Cu(I) ions bound to specific metal-binding sites on proteins react with hydrogen 
peroxide to generate hydroxyl radicals. These free radical generating systems can be replaced 
by Cu(II)/H2O2 [13-15]. MCO of proteins is mainly a site-specific process in which only one 
or a few amino acids at the metal-binding sites of the protein are preferentially oxidized 
[15,16]. Histidine and methionine are important targets of protein oxidation. 2-oxo-histidine 
was found to be the predominant product of MCO in histidine containing proteins such as 
human growth hormone [17] and human relaxin [18]. Other unidentified protein degradation 
products have been detected [18], including the formation of asparagine and/or aspartyl from 
histidyl residues [19,20], Met(O) (methionine sulfoxide) is proposed to be the major product 
of MCO of methionine [21]. Higher oxidized products of methionine may have an additional 
oxygen at the sulfur atom or at one of the carbon atoms, or addition of a perhydroxyl group 
(OOH) at the sulfur atom [22,23]. The oxidation of protein may also lead to cleavage of 
peptide bonds. Scheme 1 presents the peptide fragmentation notation. Peptide fragment ions 
are indicated by a, b, or c if the charge is retained on the N-terminus and by x, y or z if the 
charge is maintained on the C-terminus. The subscript indicates the number of amino acid 
residues in the fragment [24].  
One possible way to understand these very complicated metal ion–protein interactions 
is the study of the interaction of copper(II) ions with the short fragments of PrP. In this paper 
we report the synthesis and the studies of the interaction of copper(II) ions with the 
HuPrP(103-112) fragment (Ac−SKPKTNMKHM−NH2) and its mutants, including both 
coordination and oxidation. Methionine residues are systematically replaced with alanine 
(Ac−SKPKTNAKHA−NH2, Ac−SKPKTNAKHM−NH2 and Ac−SKPKTNMKHA−NH2) or 
displaced (Ac−MKPKTNAKHA−NH2) in the studied decapeptides The studied HuPrP 
fragment contains the −MKHM− sequence which has determent significance in the copper(II) 
ion binding, and the oxidation of histidine and methionine residues can be followed 
simultaneously in it. On the other hand, the replacement and displacement of methionine 
residues help us to clarify the role of methionine residues in these processes.  
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2. Materials and methods 
2.1 Chemicals 
Chemicals and solvents used for synthetic purposes were purchased from commercial sources 
in the highest available purity and used without further purification. 
All N-fluorenylmethoxycarbonyl (Fmoc)-protected amino acids (Fmoc-Ala-OH, Fmoc-
Asp(OtBu)-OH, Fmoc-Asn-(Trt)-OH (TrT: trityl), Fmoc-Gly-OH, Fmoc-His(Trt)-OH, Fmoc-
Lys(Boc)-OH (Boc: tert-butyloxycarbonyl), Fmoc-Met-OH, Fmoc-Pro-OH, Fmoc-Ser(tBu)-
OH és Fmoc-Thr(tBu)-OH), 2-(1-H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium 
tetrafluoroborate (TBTU) and Rink Amide AM resin was purchased from Novabiochem 
(Switzerland). N,N-diisopropyl-ethylamine (DIEA) and trifluoroacetic acid (TFA) were 
obtained from Merck Ltd. N-hydroxybenzotriazole (HOBt), N-methyl-pyrrolidone (NMP), 
triisopropylsilane (TIS), 2,2’-(ethylenedioxy)diethanethiol (DODT), and 2-methyl-2-butanol 
were Sigma-Aldrich products. Piperidine, dichloromethane (DCM), diethyl ether (Et2O), 
acetic acid (96%) and H2O2 were obtained from Molar Chemicals Ltd whereas peptide 
synthesis grade N,N-dimethylformamide (DMF), acetonitrile (ACN) and acetic anhydride 
were from VWR International Ltd. Ethylene diamine tetraacetic acid disodium salt 
(Na2EDTA) were from Reanal Ltd. 
The peptides Ac-SKPKTNMKHM-NH2 (dMKHM), Ac-SKPKTNAKHA-NH2 (dAKHA), 
Ac-SKPKTNMKHA-NH2 (dMKHA), Ac-SKPKTNAKHM-NH2 (dAKHM) and Ac-
MKPKTNAKHA-NH2 (dM1AKHA) were synthesized by means of a Liberty 1 solid phase 
peptide synthesizer. 
Concentrations of the peptide stock solutions were determined by potentiometric titrations 
that also supported the purity and the identity of the substances.  
Stock solutions of copper(II) chlorides were prepared from analytical grade reagents and their 
concentration were measured gravimetrically via the precipitation of oxinates. The other stock 
solutions (KOH, HCl, KCl, potassium hydrogen phthalate) were also prepared from analytical 
grade reagents. 
 
2.2. Peptide synthesis and purification 
The protected peptides (Scheme 2) were synthesized by means of a microwave-assisted 
Liberty 1 Peptide Synthesizer (CEM, Matthews, NC) using the Fmoc/tBu technique and the 
5 
 
TBTU/HOBt/DIPEA (DIPEA: N,N-Diisopropylethylamine) activation strategy. Removal of 
the Fmoc protecting group was carried out at 80 °C with 30 Watts microwave power for 180 s 
by means of 20% piperidine in DMF. Four times excess of amino acids and 30 W microwave 
power for 300 s were used for coupling at 80 °C in the presence of 0.5 M HOBt and 0.5 M 
TBTU in DMF as an activator and 2 M DIPEA as an activator base. In the case of the 
peptides the free amino terminus was treated with DMF containing 5 V/V% Ac2O and 6 
V/V% DIPEA to obtain the acetylated amino group. The prepared peptide linked to the resin 
was washed with dichloromethane, 96% acetic acid, 2-methyl-2-butanol and diethyl ether. 
The side chain protecting groups were cleaved with the mixture of TFA/TIS/H2O/DODT 
(94/2.5/2.5/1 V/V%) at room temperature for 2 hours. The solution containing the peptide was 
separated from the resin by filtration, followed by recovering from the pertinent solution by 
precipitation with cold diethyl ether. The precipitate was washed with cold diethyl ether, then 
was centrifuged and dried, redissolved in water and finally lyophilized. 
The purity of the peptides was checked by analytical RP-HPLC using a Jasco instrument, 
equipped with a Jasco MD-2010 plus multiwavelength detector. The chromatographic 
conditions are as follows: Column: Teknokroma Europa Protein C18 (250 x 4.6 mm, 300 Å 
pore size, 5 μm particle size); elution: gradient elution was carried out using solvent A (0.1% 
TFA in water) and solvent B (0.1% TFA in acetonitrile) at a flow rate of 1 mL·min–1, 
monitoring the absorbance at 222 nm. From 3 min to 9 min 100% to 95% (dAKHA), 92% 
(dMKHA, dAKHM, dM1AKHA), 88% (dMKHM) A, from 9 min to 24 min 95% (dAKHA), 
92% (dMKHA, dAKHM, dM1AKHA), 88% (dMKHM) A and from 24 min to 30 min 95% 
(dAKHA), 92% (dMKHA, dAKHM, dM1AKHA), 88% (dMHKM) to 100% A was applied. 
 
2.3. Potentiometric measurements 
The pH-potentiometric titrations were made in 4.00 mL samples at 3.10−3 M  ligand 
concentration with the metal ion to ligand ratio 1:1. 
The titrations were performed with carbonate free stock solution of potassium hydroxide of 
known concentration. A MOLSPIN pH-meter equipped with a 6.0234.100 combined glass 
electrode (Metrohm) was used for pH measurements (in the pH range 2.5–11.5), while the 
dosing of the titrant were made with a MOL-ACS microburette controlled by a computer. 
During the measurements argon was bubbled through the samples to ensure the absence of 
oxygen and carbon dioxide. All pH-potentiometric measurements were carried out at a 
constant ionic strength of 0.2 M  KCl and at a constant temperature (298 K). 
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The recorded pH readings were converted to hydrogen ion concentration as described by 
Irving et al [25]. Protonation constants of the ligands and overall stability (log βpqr) constants 
of the metal complexes were calculated by means of the general computational programs 
(SUPERQUAD [26] and PSEQUAD [27]) based on eqn (1) and (2). 
rqprqp LHMLHM   (1) 
 
     rqp rqppqr LHM
LHM
  (2) 
 
2.4. Spectroscopic measurements 
UV–Vis spectra of the complexes were recorded on Hewlett Packard HP 8453 diode array 
and Perkin Elmer Lambda 25 double beam spectrophotometers. The same concentration range 
was used as for pH-potentiometry.  
Circular dichroism spectra of the complexes were registered on a JASCO J-810 
spectropolarimeter using 1 mm and/or cm cells in the 200–800 nm wavelength range at the 
same concentrations as used in pH-potentiometry. 
 
2.5. Oxidation of Human Prion fragment and its mutants 
The reaction mixture containing 1.1 mM  of peptides and metal-to-ligand molar ratio 1:1.1 
was incubated at 25 °C for 1 h in the presence of hydrogen peroxide at metal to H2O2 molar 
ratio 1:4 for all peptides. The pH was adjusted to 7.4. The reaction was started by the addition 
of hydrogen peroxide, which was freshly prepared. After incubation the reaction was stopped 
by addition of Na2EDTA at ligand to Na2EDTA ratio 1:5. The reaction process was monitored 
by RP-HPLC at different time periods. The chromatograms of the reaction mixtures after 1 
hour 2, 4 and 24 and 96 hour indicated no significant difference (the shape, retention times 
and intensity of peaks) suggesting the end of reaction after 1 hour. 
 
2.6. Isolation of oxidized products 
The samples were analyzed by analytical RP-HPLC using a Jasco instrument, equipped with a 
Jasco MD-2010 plus multiwavelength detector. The oxidized products were conducted on a 
Teknokroma Europa Protein C18 (250 x 4.6 mm, 300 Å, 5 μm) at a flow rate of 1 mL·min–1, 
monitoring the absorbance at 222 nm. Mobile phases were water (A) and acetonitrile (B) 
containing 0.1% TFA. Gradient: 0-3-9-24-30 min, 100-100-95-95-100% water containing 
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0.1% TFA for dAKHA; 0-3-9-24-30 min, 100-100-92-92-100% water containing 0.1% TFA 
for dAKHM, dMKHA, dM1AKHA; 0-3-9-24-30 min, 100-100-88-88-100% water containing 
0.1% TFA for dMKHM. 
The oxidized mixture was separated by RP-HPLC semipreparative 218 TP C18 Grace Vydac 
column (250 x 10 mm, 5μm). Reverse phase HPLC was performed on a Jasco instrument, 
equipped with a Jasco UV-2077 Plus 4-λ Intelligent UV/Vis detector. The flow rate of 3 
mL·min–1 was maintained. The elution of peptides was monitored by UV absorbance at 222 
nm. Above mentioned gradient elution was used at this system. 
 
2.7. Mass spectrometry 
A MicroTOF-Q type Qq-TOF MS instrument (Bruker Daltonik, Bremen, Germany) was used 
for the MS and MS/MS measurements in positive ion mode. The instrument was equipped 
with an electrospray ion source where the spray voltage was 4 kV. N2 was utilized as drying 
gas. The drying temperature was 200 °C and the flow rate was 4.0 L/min (8.0 L/min HPLC-
MS) using the same method described in 2.6. For the MS/MS experiments, nitrogen was used 
as the collision gas. The pressure in the collision cell was determined to be 1.2×10–2 mbar. 
The precursor ions for MS/MS were selected with an isolation width of 5 m/z units. The mass 
spectra were recorded by means of a digitizer at a sampling rate of 2 GHz. The mass spectra 
were calibrated externally using the exact masses of clusters [(NaTFA)n+Na]+ generated from 
the electrosprayed solution of sodium trifluoroacetate (NaTFA). The spectra were evaluated 
with the DataAnalysis 3.4 software from Bruker.  The sample solutions were introduced either 
directly into the ESI source with a syringe pump (Cole-Parmer Ins. Co., Vernon Hills, IL, 
USA) at a flow rate of 3 μL/min. 
 
 
3. Results and discussion 
3.1. Protonation equilibria of the peptides 
The protonation constants of the ligands were determined by pH-potentiometric 
measurements and the pK values are included in Table 1 together with the stability constants 
of the copper(II) complexes. It is clear from Table 1 that all decapeptides have four 
protonation sites which can be assigned to the imidazole nitrogen atom of His111 and -
amino groups of Lys104, Lys106 and Lys110. The protonation reactions of the imidazole 
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nitrogen atoms of histidyl and the -amino groups of lysyl residues are well separated and 
take place in the pH ranges 5.5-7.0 and 9.5-11.5, respectively. These values are in good 
agreement with other fragments of prion proteins [28]. 
 
3.2. Copper(II) complexes of the peptides 
Since the studied ligands contain only one anchor group, namely histidine imidazole nitrogen, 
and according to the previous observations [28], it was suggested that only 1:1 complexes are 
formed. Therefore the copper(II)-peptide systems were investigated only at 1:1 metal ion-to 
ligand ratio. The metal ion speciations of the five systems are very similar to each other, this 
is represented by Figure 1. It is clear from Table 1 and Figure 1 that, in all systems, complex 
formation starts around pH 4, forming [CuH3L]5+ species, in which monodentate binding of 
the histidyl residue is expected, while all the lysyl residues remain protonated. The lack of 
circular dichroism (CD) activity below pH 5.5 and the calculated pK value for the formation 
of this complex provide further support for this assumption. The deprotonation of the amide 
nitrogens occurs above pH 5, in a cooperative manner, forming the [CuHL]3+ = [(CuH–
2L)H3]3+ species. This process is accompanied with a significant blue shift of the absorption 
spectra and the appearance of the N−→Cu2+ CT bands (max = 330-350 nm) in the CD spectra 
(Figure 2). The three uncoordinated lysyl side chains remain protonated in the (Nim, N−, N−)-
bonded species. In addition to a weak interaction of thioether sulfur atoms of methionine can 
be supposed in the copper(II)-peptide systems, in which Met109 is present. It is supported by 
the CD spectra, where a positive Cotton effect observed around 380 nm. It can be attributed to 
the S(thioether)→Cu2+ CT transitions supporting the equatorial coordination of the thioether 
residues. However this interaction is much lower than it is in the case of smaller prion 
fragments [28], which can be explained by the size of the peptides; the long peptide chain 
hinders the binding of donor atoms due to its flexibility. 
The deprotonation of the third amide nitrogen takes place above pH 7 resulting the [CuL]2+ 
species. There is an absorption maximum around 530 nm which refers to 4N coordination. 
The S(thioether)→ Cu2+ CT disappears at the same time (Figure 2). The thioether sulfur atom 
is displaced by the third amide nitrogen resulting in a stronger interaction. However, the 
formation of [CuH−1L]+, [CuH−2L] and [CuH−3L]– species are not accompanied by any change 
neither in the absorption nor in the CD spectra. The deprotonation of the lysine ammonium 
groups occurs in these cases. If the pK values of these processes are compared with the pK 
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values of the lysine in the free ligand, it can be stated that the lysine side chains do not take 
part in the coordination of the copper(II) ion. 
If the copper(II) complexes of the studied ligands are compared it is obvious that there is no 
significant difference in the complex formation reactions, neither in their stabilities, nor in 
their spectroscopic parameters. 
 
3.3. Oxidation of the peptides 
3.3.1. Oxidation of dAKHA 
This mutant contains only His111 as the only target of metal-catalyzed oxidation, no 
methionine residue is present. The oxidation of the peptide was carried out at pH 7.4. At this 
pH there are (NIm,N–,N–)-bonded [CuHL]3+ species in equilibrium with the (NIm,N–,N–,N–)-
bonded [CuL]2+ species. 
The HPLC chromatograms indicate that there is no change in comparison to the peptide, if the 
solution contains only Cu(II) and the peptide, or H2O2 and the peptide. Both Cu(II) and H2O2 
is needed for the oxidation of dAKHA.  
The oxidation of this peptide resulted several products, which is presented on Figure 3. The 
intensity of these peaks are very low, therefore the identification with LC/MS is not possible. 
Hence the products were separated by semi-preparative column, and the individual products 
were studied in MS and MS/MS. The formation of 2-oxo-histidine derivative was not detected 
in the MS spectra, the fragmentation of the peptide chain occurred. There are two possible 
mechanism for this process; the α-amidation and the diamide pathways [29]. However, only 
the product ions from the fragmentation of the ligand by the α-amidation pathway could be 
observed with significant intensities. The C-terminal amino acid of the fragment derived from 
the N-terminal region of the protein exists as the amide derivative and the N-terminal amino 
acid of the fragment derived from the C-terminal portion of the protein exists as an α-keto-
acyl derivative. The most abundant product ions are c4+, observed at m/z 500.316 (calculated 
value 500.319), c62+ at m/z 358.212 (calculated value 358.208) and c72+ at m/z 393.722 
(calculated value 393.727). The cleavage of Lys4-Thr5, Asn6-Ala7 and Ala7-Lys8 peptide 
bonds can be detected. Furthermore the ion y3+ is also detected, which is formed on another 
pathway. The charge of all the identified ions arises from the presence of protons. 
The presence of c7 ion as a product of oxidation is proved by the MS/MS spectra on Figure 4. 
c7 ion has 2 positive charge with m/z 393.722 (calculated value 393.727). The first step is the 
loss of ammonia, resulting doubly charged b7 ion at m/z 385.289. Then the loss of alanine can 
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be seen, forming doubly charged b6 ion at m/z 349.686. Singly charged b6 ion is also formed 
at m/z 698.384. The loss of Asn6 and Thr5 resulting the b5+ and b4+ ions, is also very well 
tracked. 
 
3.3.2. Oxidation of mutant peptides containing one methionine residue (dMKHA and 
dAKHM) 
Only one product was formed during the oxidation of these peptides. The mass difference 
between the untreated and the oxidized mutant peptides based on the MS measurements 
corresponds to the mass of the oxygen atom (15.995) indicating the successful oxidation of 
these peptides by the addition of one oxygen. Then MS/MS measurements were performed to 
identify the place of the oxidation in the peptides. It is proved that the oxidation of the 
methionine to methionine sulfoxide occurred in both cases, but the results will be shown in 
details only for the peptide dAKHM. Chromatographic peak eluting at 20.6 min and in the 
MS spectra occurring at m/z 599.826 (calculated value 599.822) correspond to the doubly 
charged molecular ion of dAKHM after oxidation ([y10+O]2+). The fragmentation of this ion 
is presented on Figure 5. It begins on the N-terminus, and the amino acids are removed step 
by step. All the fragments contain the oxygen atoms, since the methionine residue (Met109) is 
on the C-teminus. The final fragment is [y1+O]+ with 165.070 m/z (calculated 165.069), 
which is the oxidized form of methionine. A peak corresponding to the loss of CH3SOH 
(63.998) are observed at m/z 567.826 (calculated value 567.823) with [y10+O−CH3SOH]2+ 
stoichiometry. It is also diagnostic for the formation and presence of methionine sulfoxide 
[30].  
The molecular weight of dMKHA and the mass of its oxidized product are equal to these 
values of dAKHM, the only difference is in the position of the methionine residue. The 
oxidation of the methionine residue (Met112) at position 7 is proved, it is confirmed by the 
above mentioned loss of CH3SOH. However, fragments supporting the oxidation of histidine 
were not identified. e.g. [y2]+ fragment with 226.135 m/z (calculated value 226.130) contains 
only histidine and alanine, [y2+O]+ did not revealed. 
3.3.3. Oxidation of dMKHM 
Several products were formed during the oxidation of this prion protein fragment (Figure 6). 
The products were separated by semi-preparative column, and the individual products were 
studied in MS. Two main products can be identified. This peptide was not fragmentized, only 
the addition of one or two oxygen atoms can be seen. The species eluted at 12.0 min is a 
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doubly oxidized, the species eluted at 13.2 min is a singly oxidized product. According the 
MS/MS measurements it is proved that only the methionine residue is oxidized, the histidine 
residue did not change during the oxidation.  
The species with 637.818 m/z (calculated 637.821) has two positive charges due to the 
presence of the hydrogen atoms. The mass of this ion is 31.990 units higher than that of the 
nonoxidized peptide. This species is named as [y10+2O]2+, corresponding to the addition of 
two oxygen atoms to the fragment. The fragmentation of this species begins at the N-terminal 
part of the peptide; it is shown on Figure 7. Fragments containing only even-numbered amino 
acids, namely y8+2O, y6+2O and y4+2O, could be identified. The loss of amino acids occurred 
in pairs. The latter fragment still contains two oxygen atoms, its sequence is 
MetLysHisMet+2O. The additional oxygen atoms could stay either on the histidine or on the 
methionine residues. Histidine is also dispose for oxidation, but it was not detected in our 
case. There are several proofs for the oxidation of the methionine residues; for example a 
peak with m/z: 165.069 (calculated 165.069) for [MetO]+. However, the oxidized histidine 
(His+O) or any loss referring the to the oxidation of this amino acid residue was not observed 
at all in the MS/MS spectra. It is obvious from the MS/MS spectra that only methionine 
sulfoxides are produced, neither methionine sulfone nor histidine-oxide is formed. 
The singly oxidized products are observed at 629.820 m/z (calculated 629.824), namely 
[y10+O]2+. Both methionine residues at position 7 (Met109) and at position 10 (Met112) can 
be oxidized respectively. None of these residues is preferred over the other one; their 
oxidation occurs randomly. However, the two products are not separated in the HPLC 
chromatogram.  
Oxidation of the Met109 residue can be proved by the [b9+O]2+ with 555.788 m/z (calculated 
555.790) and the [y2]+ with 286.130 m/z (calculated 286.134) peaks. [b9+O]2+ contains the 
oxygen atom on Met109 since the C-terminal Met112  is removed. If eight amino acids are 
fragmented from the N-terminal part of the oxidized product yields [y2]+ fragment, in which 
Met112 is present, the oxygen atom is removed with Met109. 
Oxidation of the Met112 residue can be proved by [y2+O]+ with 302.127 m/z (calculated 
302.129) and [y1+O]+ with 165.069 m/z (calculated 165.069) peaks. [y2+O]+ contains only 
one methionine, therefore oxygen atom is on this Met112. In the latter fragment the oxygen 
could be on the histidine residue, however the [y1+O]+ fragment still contains the oxygen 
atoms, therefore the oxidation of Met112 is proved. 
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In the case of the studied peptides which contain methionine in close vicinity of the metal-
binding site, the oxidation of this group occurred. Therefore a newer mutant peptide was 
synthesized and studied in which the methionine is far from the coordinated metal ion.  
3.3.4. Oxidation of dM1AKHA 
The serine is replaced by methionine residue and the methionine residues are replaced by 
alanine in this mutant peptide. The condition of oxidation was the same. The oxidation of the 
peptide occurred. The oxidation of the methionine residue is proved again by MS/MS (Figure 
8). [y10+O]2+ with 591.821 m/z (calculated 591.824) is the main product, the loss of CH3SOH 
group results in [y10+O−CH3SOH]2+ with 559.823 m/z (calculated 559.825) which is 
consistent with the oxidation of the methionine residue. There are several other proofs for it. 
[b1+O]+ is the oxidized form of acetil-methionine with 190.055 m/z (calculated 190.054). The 
identified y fragments do not contain oxygen with the exception of the methionine containing 
y10. 
 
4. Conclusions 
The coordination chemistry of the five studied decapeptides is rather similar to each other 
including the stability and the coordination mode of the copper(II) complexes. The only 
difference is, that in the peptides which contain Met109, in addition to the (Nim,N−,N−) 
coordination mode, a weak interaction  of thioether sulfur atoms can be supposed.  
The histidine residue behaves as an anchor site, and the (Nim,N−,N−/Nim,N−,N−,N−) 
coordination modes prevent the oxidation of this side chain. The mutant peptide which does 
not contain methionine did not undergo oxidation, only the fragmentation of the peptide chain 
is perceived. The cleavage of the peptide bonds occurred far away from the histidine residue. 
However, in the case of methionine containing peptides, the peptide chain was not cleaved; 
the presence of methionine residues protects the peptides from fragmentation. In these cases 
copper(II) ions catalyze the oxidation of methionine to methionine sulfoxide. This process 
occurs randomly, it does not depend on the position of the methionine; methionine residues 
undergo oxidation either involved in the coordination of the copper(II) ions, or near or far the 
binding sites. Methionine  oxidation is considered to be a destabilizing trigger that causes the 
cascade of events leading to PrP misfolding [31,32]. However, the sizes of the studied 
decapeptides are too short for reaching so extensive conclusions. Our results revealed that 
methionine residues of prion protein can play a role as ROS scavenger. The oxidation of 
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methionine residues in these short peptides containing only one histidine is able to protect the 
peptides from oxidation and degradation. To decide whether this effect of methionine prevails 
in the prion protein as well and to understand that these oxidation processes how affect the 
misfolding of proteins the longer fragments containing two or more histidines will be studied 
in continuation of our work. 
 
Abbreviation: 
ACN acetonitrile 
CD circular dichroism spectroscopy
dAKHA Ac-SKPKTNAKHA-NH2 
dAKHM Ac-SKPKTNAKHM-NH2 
DCM dichloromethane 
DIEA N,N-diisopropyl-ethylamine 
DIPEA N,N-Diisopropylethylamine
DMF N,N-Dimethylmethanamide
dM1AKHA Ac-MKPKTNAKHA-NH2 
dMKHA Ac-SKPKTNMKHA-NH2 
dMKHM Ac-SKPKTNMKHM-NH2 
DODT 2,2′-(Ethylenedioxy)diethanethiol
Fmoc Fluorenylmethyloxycarbonyl
HOBt 1H-Benzotriazol-1-ol  
Hu-PrPC cellular human prion protein  
MCO metal ion-catalyzed oxidation 
MS mass spectrometry 
NMP N-methyl-pyrrolidone 
ROS reactive oxygen species 
RP-HPLC Reversed-Phase High-Performance Liquid Chromatography 
TFA trifluoroacetic acid 
TBTU 2-(1H-Benzotriazole-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate 
tBu tert-Butyl 
TFA trifluoroacetic acid 
TIS triisopropylsilane 
TrT trityl 
TSEs transmissible spongiform encephalopathies 
UV-Vis UV-visible spectroscopy 
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Table 1: pK values and stability constants of the copper(II) complexes of the studied peptides  
(I = 0.2 M KCl, T = 298 K, standard deviations are in parentheses)  
 
 
 
  
  
  
  
Ac−SKPKTN
AKHA−NH2 
(dAKHA) 
Ac−SKPKTN
AKHM−NH2 
(dAKHM) 
Ac−SKPKTN
MKHA−NH2 
(dMKHA) 
Ac−SKPKTN
MKHM−NH2 
HuPrP(103-
112) 
(dMKHM) 
Ac−MKPKTN
AKHA−NH2 
(dM1AKHA) 
Ac−KTNMK
HMAG−NH2 
HuPrP(106–
114) [28] 
pK(Im) 6.28(2) 6.15(1) 6.23(2) 6.15(2) 6.20(5) 6.24 
pK(Lys1) 9.80(2) 9.73(1) 9.77(1) 9.75(2) 9.62(4) 9.91 
pK(Lys2) 10.37(1) 10.36(1) 10.34(1) 10.34(1) 10.39(3) 10.54 
pK(Lys3) 10.97(2) 10.76(1) 11.05(2) 10.92(2) 10.75(4) − 
CuLH3 34.67(2) 34.53(4) 35.01(2) 34.84(2) 34.73(4)  
CuLH2      23.54 
CuLH 22.56(1) 22.69(2) 23.21(1) 23.28(2) 22.46(2) 17.61 
CuL 15.03(2) 15.06(3) 15.73(2) 15.82(2) 14.69(3) 12.39 
CuLH−1 5.29(2) 5.31(3) 5.94(2) 6.08(3) 4.99(4) 4.56 
CuLH−2 −5.16(2) −5.36(4) −4.53(2) −4.43(3) −5.56(4) –5.45 
CuLH−3 −15.99(2) −15.94(3) −15.40(2) −15.14(2) −16.13(4) –16.11 
pKamide(1−2)  6.06 5.92 5.9 5.78 6.14 5.58 
pKamide(3) 7.53 7.63 7.48 7.46 7.77 7.83 
lgK(Cu+L) 3.53 3.68 3.85 3.83 3.97 3.09 
 Scheme
 
 
1: Peptide fragmentati
 
on notation
17 
 using the scheme of Roepstorff and Fohlman [24]  
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Scheme 2 
 
 
 
 
 
R1, R2, R3 = A/M/S 
A = -CH3 
M = -CH2-CH2-S-CH3 
S = -CH2-OH 
 
  
Peptide R1 R2 R3 
dAKHA S A A 
dAKHM S A M 
dMKHA S M A 
dMKHM S M M 
dM1AKHA M A A 
19 
 
Figure legends 
Figure 1: Species distribution of the complexes formed in the copper(II)–decapeptides 
systems (cCu(II) = cL = 3 · 10–3 M) as a function of pH. 
Figure 2: Circular dichroism spectra of the (NIm,N–,N–)-bonded [CuHL]3+ and the (NIm,N–,N–
,N–)-bonded [CuL]2+ complexes formed in the studied system 
Figure 3: HPLC chromatogram of the products forming during the oxidation of dAKHA 
Figure 4: Fragmentation of c7 ion formed during the oxidation of dAKHA 
Figure 5: MS/MS spectrum of the oxidized product of dAKHM 
Figure 6: HPLC chromatogram of the products forming during the oxidation of dMKHM 
Figure 7: MS/MS spectra of the double oxidized product of dMKHM 
Figure 8: MS/MS spectrum of the oxidized product of dM1AKHA 
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